DNA RNA and Cells

30 Nov 2009 Kiadis Pharma announces enrollment of first patients in a multinational registration study for ATIR
25 Nov 2009 Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement
25 Nov 2009 Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants
24 Nov 2009 MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
23 Nov 2009 BioAlliance Pharma presents efficacy and safety preclinical results for its AMEPā„¢ anti-invasive biotherapy at the ESGCT Annual Congress in Hannover, November 21 to 25, 2009
19 Nov 2009 AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
19 Nov 2009 Altair Therapeutics Announces Commencement of a Multi-Center Phase IIa Clinical Trial of Inhaled AIR645 to Treat Asthma
19 Nov 2009 Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR-NCI-EORTC
19 Nov 2009 Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells to Treat Eye Disease
19 Nov 2009 Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML)
18 Nov 2009 Jennerex and Lee's Pharmaceuticals Announce Partnership for JX-594 in China
18 Nov 2009 Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer
18 Nov 2009 Aldagen Announces Clinical Data for ALD-201 for Ischemic Heart Failure Presented at AHA
17 Nov 2009 Study Meets Primary Endpoint with 25 Percent LDL Reduction in Very High-Risk Patient Population
16 Nov 2009 ReNeuron presents positive pre-clinical efficacy data with ReN009 stem cell therapy for peripheral arterial disease at leading US scientific conference
16 Nov 2009 Interim Results From Aastrom's IMPACT-DCM Cardiac Trial Presented at The American Heart Association Meeting
16 Nov 2009 Genta Announces Results of AGENDA Phase 3 Trial of GenasenseĀ® in Patients with Advanced Melanoma
16 Nov 2009 Phase 1/2 Results for Aldagen's ALD-301 Critical Limb Ischemia Clinical Study Presented at AHA
12 Nov 2009 Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology
11 Nov 2009 Geron Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord Injury
11 Nov 2009 AMT Successful in Preclinical Treatment of DMD
11 Nov 2009 Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
10 Nov 2009 MOLOGEN applies for clinical study with cell-based gene therapy for renal cancer
09 Nov 2009 Zosano Pharma, Inc. Announces Publication of Positive Phase 2 Study of Its ZP-PTH Patch for Osteoporosis Therapy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up